First Oral Drug Atogepant Effective in Reducing Number of Mi
A Study was conducted to assess the effectiveness of oral Atogepant for the preventive treatment of migraine. The researchers screened a total of 2270 participants. Results showed that the changes from baseline across 12 weeks were 3.7 days with 10-mg atogepant, 3.9 days with 30-mg atogepant, 4.2 days with 60-mg atogepant, and 2.5 days with placebo. In particular, Once-daily oral Atogepant is effective in reducing the number of headache days and migraine days over a period of 12 weeks.

If you find this post insightful, please like, comment and share.

Source:
https://www.nejm.org/doi/full/10.1056/NEJMoa2035908
A●u A●●●r L●●●●r and 3 others like this1 share
Like
Comment
Share